Qube Research & Technologies Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 144 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2022$1,249,280
+185.9%
84,525
+144.3%
0.01%
+133.3%
Q2 2022$437,000
-64.2%
34,598
-46.5%
0.00%
-70.0%
Q1 2022$1,222,000
+222.4%
64,612
+382.1%
0.01%
+66.7%
Q1 2021$379,000
+9.5%
13,402
-30.9%
0.01%
-97.4%
Q3 2019$346,000
-21.4%
19,395
-3.0%
0.23%
+119.0%
Q2 2019$440,00020,0000.10%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,684,118$84,523,00016.48%
Cederberg Capital Ltd 3,400,000$108,868,0002.00%
Capital International Sarl 570,500$18,267,0001.91%
AIA Group Ltd 437,118$14,971,0001.72%
Capital International, Inc./CA/ 4,711,405$150,859,0001.40%
M&G INVESTMENT MANAGEMENT LTD 3,096,345$99,083,0000.62%
Bellevue Group AG 947,674$30,345,0000.35%
Sands Capital Management 7,051,916$225,802,0000.22%
E Fund Management (Hong Kong) Co., Ltd. 18,836$603,0000.21%
Hudson Bay Capital Management LP 1,031,212$33,020,0000.18%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders